Home LiteratureArticle Details
PMID: 12379733 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli.

Infection and immunity ·Vol. 70 ·No. 11 ·2002-11-00 ·Pages 6481-4

Hull RA, Donovan WH, Del Terzo M, Stewart C, Rogers M, Darouiche RO

Abstract

Recent clinical studies suggest that the deliberate colonization of the human bladder with a prototypic asymptomatic bacteriuria-associated bacterium, Escherichia coli 83972, may reduce the frequency of urinary tract infection in individuals with spinal cord injuries. However, the mechanism by which E. coli 83972 colonizes the bladder is unknown. We examined the role in bladder colonization of the E. coli 83972 genes papG and fimH, which respectively encode P and type 1 receptor-specific fimbrial adhesins. E. coli 83972 and isogenic papGDelta and papGDelta fimHDelta mutants of E. coli 83972 were compared for their capacities to colonize the neurogenic human bladder. Both strains were capable of stable colonization of the bladder. The results indicated that type 1 class-specific adherence and P class-specific adherence, while implicated as significant colonization factors in experiments that employed various animal model systems, were not required for colonization of the neurogenic bladder in human beings. The implications of these results with regard to the selection of potential vaccine antigens for the prevention of urinary tract infection are discussed.

MeSH Terms
Adhesins, Escherichia coli/genetics,physiology Alleles Bacterial Adhesion Escherichia coli/genetics,physiology Fimbriae Proteins/genetics,physiology Fimbriae, Bacterial/physiology Humans Urinary Bladder, Neurogenic/microbiology
Chemicals
Adhesins, Escherichia coli PapG protein, E coli fimH protein, E coli Fimbriae Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hull Richard A
Department of Molecular Virology and Microbiology, Center for Prostheses Infections, Baylor College of Medicine, Houston, Texas 77030, USA. rhull@bcm.tmc.edu
Donovan William H
Del Terzo Michael
Stewart Colleen
Rogers Margaret
Darouiche Rabih O
References (15)
15 references, click to expand
  1. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.
    J Urol. 2000 Mar;163(3):872-7 PMID: 10687996
  2. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria.
    Infect Immun. 1999 Jan;67(1):429-32 PMID: 9864249
  3. Pilot trial of bacterial interference for preventing urinary tract infection.
    Urology. 2001 Sep;58(3):339-44 PMID: 11549475
  4. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside.
    J Infect Dis. 1979 Mar;139(3):329-32 PMID: 376757
  5. Contribution of adhesion to bacterial persistence in the mouse urinary tract.
    Infect Immun. 1983 Apr;40(1):265-72 PMID: 6131870
  6. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
    Infect Immun. 1985 Nov;50(2):370-7 PMID: 2865209
  7. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence.
    Infect Immun. 1991 Sep;59(9):2915-21 PMID: 1879917
  8. Multifunctional nature of P fimbriae of uropathogenic Escherichia coli: mutations in fsoE and fsoF influence fimbrial binding to renal tubuli and immobilized fibronectin.
    Mol Microbiol. 1991 Dec;5(12):2965-75 PMID: 1687325
  9. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain.
    Mol Microbiol. 1993 Oct;10(1):143-55 PMID: 7968511
  10. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9827-32 PMID: 8790416
  11. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Science. 1997 Apr 25;276(5312):607-11 PMID: 9110982
  12. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    J Clin Invest. 1997 Sep 1;100(5):1123-36 PMID: 9276729
  13. Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization.
    J Bacteriol. 1997 Oct;179(20):6228-37 PMID: 9335267
  14. Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases.
    J Urol. 1998 Jun;159(6):2057-62 PMID: 9598517
  15. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract.
    Mol Microbiol. 2000 Nov;38(3):456-64 PMID: 11069670
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2002-11-00
Pages
6481-4
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC130346
Subset
IM
Grants
NICHD NIH HHS · HD35856 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com